Drug-resistant epilepsy remains a therapeutic challenge, requiring new molecular targets beyond conventional antiepileptic drugs. Small-conductance calcium-activated potassium (SK) channels and Na/K-ATPase (NKA) contribute to afterhyperpolarization via distinct mechanisms, offering complementary ways to suppress hyperexcitability. We examined SK activation and NKA modulation in synchronized epileptiform activity in a primary culture of cortical neurons obtained from rat embryos. Epileptiform discharges were induced by magnesium-free solution and assessed by patch-clamp and calcium imaging. The SK2/3 activator CyPPA (10 µM) reduced epileptiform current (EC) amplitude and integral and decreased synchronized calcium transient (CT) frequency but gradually elevated basal calcium. In contrast, ouabain (1 nM), a selective modulator of high-affinity NKA isoforms, attenuated EC amplitude, strongly suppressed CTs, and showed persistent effects after washout, accompanied by asynchronous glial calcium activity. Co-application of CyPPA with ouabain abolished CyPPA-induced calcium elevation while maintaining suppression of neuronal synchrony. The broader SK/IK activator NS309 (10 µM) reduced CT frequency and basal calcium without affecting glia. Thus, SK activation and NKA signaling suppress epileptiform synchronization through distinct yet convergent pathways: SK channels via afterhyperpolarization and NKA via afterhyperpolarization and calcium-dependent signaling. Their combination enhances efficacy and prevents adverse calcium buildup, supporting SK–NKA co-targeting as a strategy against drug-resistant epilepsy.
Low concentrations of ouabain exert neuromodulatory effects beyond classical Na+/K+-ATPase inhibition, but the underlying mechanisms remain incompletely understood. Here, we investigated the involvement of Na+/Ca2+ exchangers (NCXs) in the modulation of spontaneous and evoked excitatory synaptic transmission by 1 nM ouabain. In cultured cortical neurons, ouabain reduced miniature excitatory postsynaptic current (mEPSC) frequency by approximately 4-fold without affecting amplitude. This effect was prevented by the broad-spectrum NCX inhibitor CB-DMB but persisted in the presence of the preferential NCX1 inhibitor SEA0400. In hippocampal CA1, ouabain increased the slope of evoked field excitatory postsynaptic potentials (fEPSPs) by approximately 34%. SEA0400 also potentiated fEPSPs, with additional potentiation observed upon sequential application of ouabain and SEA0400. In contrast, CB-DMB (NCX1–3 inhibitor) increased the fEPSP slope but prevented further potentiation by ouabain. These findings demonstrate differential modulation of spontaneous and evoked excitatory synaptic transmission by nanomolar ouabain and support the involvement of NCX-sensitive mechanisms, potentially including NCX2 and/or NCX3. Our results suggest that functional coupling between Na+/K+-ATPase and NCX-dependent Na+ and Ca2+ homeostasis contributes to the neuromodulatory effects of low ouabain concentrations.